Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $5000.0.

  • Palisade Bio's Interest Expenses fell 1666.67% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11000.0, marking a year-over-year decrease of 1538.46%. This contributed to the annual value of $12000.0 for FY2024, which is 2000.0% down from last year.
  • Per Palisade Bio's latest filing, its Interest Expenses stood at $5000.0 for Q3 2025, which was down 1666.67% from $2000.0 recorded in Q2 2025.
  • Palisade Bio's 5-year Interest Expenses high stood at $1.7 million for Q1 2021, and its period low was $1000.0 during Q1 2022.
  • In the last 5 years, Palisade Bio's Interest Expenses had a median value of $4000.0 in 2022 and averaged $143529.4.
  • In the last 5 years, Palisade Bio's Interest Expenses skyrocketed by 6624354.4% in 2021 and then plummeted by 9994.16% in 2022.
  • Palisade Bio's Interest Expenses (Quarter) stood at $26000.0 in 2021, then plummeted by 88.46% to $3000.0 in 2022, then surged by 33.33% to $4000.0 in 2023, then dropped by 25.0% to $3000.0 in 2024, then soared by 66.67% to $5000.0 in 2025.
  • Its Interest Expenses was $5000.0 in Q3 2025, compared to $2000.0 in Q2 2025 and $1000.0 in Q1 2025.